Clinical Trial Update: Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates treatment of drug-eluting stent in-stent restenosis using the SeQuent Please paclitaxel-eluting PTCA catheter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• SeQuent Please Paclitaxel Eluting PTCA Catheter (paclitaxel-eluting balloon catheter)

Snippet

Sponsor: Klinikum Coburg | Conditions: In-Stent Restenosis | Phase 2 | Status: UNKNOWN